Can humans really live to 150? In this video, Prof. Dato’ Sri Dr. Mike Chan of European Wellness Biomedical Group breaks down why organ transplants alone aren’t the answer and how cellular regeneration, stem cells, and mitochondrial peptides could hold the real key to extending healthspan and longevity. Learn more at https://european-wellness.eu/ From hot-mic whispers of World Leaders to groundbreaking science, Prof. Mike Chan reveals why cellular regeneration — not organ swaps, holds the key to ext ...

From hot-mic whispers of World Leaders to groundbreaking science, Prof. Mike Chan reveals why cellular regeneration — not organ swaps, holds the key to extending human healthspan and lifespan. A Whisper in Beijing BEIJING, Sept. 30, 2025 (GLOBE NEWSWIRE) -- European Wellness Biomedical Group (EWBG), a global leader in regenerative medicine, today announced the publication of two landmark scientific contributions to the field of longevity science: the Human Cytology Atlas, mapping over 400 distinct human cel ...

股价表现 - ProKidney股价单日暴涨515%至3 73美元 而标普500指数下跌0 1% 道琼斯工业平均指数下跌0 4% [1] - 股价波动剧烈 交易区间为0 46美元至4 86美元 最终收于区间上沿 [2] 临床试验进展 - 公司公布REGEN-007二期临床试验顶线结果 显示rilparencel自体细胞疗法对慢性肾病合并糖尿病患者具有统计学和临床意义的疗效 [2] - RMCL-002试验持续推进 React技术平台持续获得市场关注 [4] 行业动态 - 竞争对手FibroGen股价上涨4 7% Vertex Pharmaceuticals上涨1 5%至466 36美元 显示肾脏治疗领域整体受到市场追捧 [3] - 与采用药物干预的竞争对手不同 ProKidney的细胞再生疗法代表慢性肾病治疗的潜在变革性方向 [4] 技术优势 - 公司专有React技术平台通过促进细胞再生治疗慢性肾病 与行业主流药物干预路径形成差异化 [4]